Top EU Firms Cut Investment Less than US Rivals, but Europe Still Well Behind

The European Commission's 2010 "EU Industrial R&D Investment Scoreboard" shows that R&D investment by top EU companies fell by 2.6% in 2009, even though sales and profits fell much more, by 10.1% and 21.0% respectively. The fall in R&D investment by leading players in the US, at 5.1%, was twice as sharp as in the EU, but the worldwide reduction was lower, at 1.9%. Japanese firms maintained their level of investment. Companies based elsewhere in Asia - China, India, Hong Kong, South Korea and Taiwan - continued the high R&D growth seen in previous years. Japanese car maker Toyota is the world's biggest R&D investor (€6.8bn) for the second consecutive year. Three EU companies feature in the top ten: Volkswagen, the biggest investor based in Europe with €5.8bn, Nokia and Sanofi-Aventis. The Scoreboard covers the top 1400 companies worldwide.

Máire Geoghegan-Quinn, Commissioner for Research, Innovation and Science said: "The fact that major EU firms have largely maintained their R&D investment shows that they recognise R&D as key to emerging stronger from the crisis. But the wide gap with the top US companies in areas like software and biotechnology and the continuing rapid rise of Asian-based companies highlight the innovation emergency Europe is facing. We urgently need heads of state and government at the December European Council to back the Innovation Union proposals that Antonio Tajani and I announced on 6 October."

This year's Scoreboard shows that despite almost unprecedentedly difficult economic conditions R&D investment remains an important strategic priority for top firms worldwide.

Trends in world regions
During 2009, leading EU companies reduced R&D investments much less than their US counterparts despite similar drops in sales (around 10%) and higher drops in profits (13.0% as against 1.4%)

European companies' R&D performance is weak in key hi-tech sectors. For example the US companies featured in the Scoreboard invested five times more than their EU counterparts in R&D on semiconductors, four times more in software R&D and eight times more in biotechnology.

Japanese companies maintained R&D investment despite strong decreases in sales (around 10%) and profits (88.2%).

Major companies headquartered in some Asian countries continued the high R&D growth of previous years, e.g. China (up 40.0%), India (27.3%), Hong Kong (14.8%), South Korea (9.1%) and Taiwan (3.1%). Swiss companies also increased R&D investment (2.5%).

Company and sector trends
Three companies headquartered in the EU are among the top ten R&D investors (Volkswagen, Nokia and Sanofi-Aventis), along with three from the US (Microsoft, Pfizer and Johnson & Johnson), and one from Japan (Toyota, in top position). The top 50 includes 16 EU companies, 19 US firms and 12 from Japan (fig. 2). 30 of the top 50 cut R&D investment in 2009.

Despite the crisis, the sectoral composition of R&D investment worldwide has remained broadly the same. For US companies, high R&D-intensity sectors, such as pharmaceutical or computer services, contribute to more than two-thirds of the total R&D. By contrast, for European and Japanese companies, medium-high R&D intensity sectors (for example automobiles or electronics) predominate, while the high R&D intensity sectors constitutes only around one-third of the total investment.

There were massive reductions in R&D investment by some automotive firms, e.g. Ford (32.4%), Renault (26.5%) and General Motors (24.1%). Others such as Nissan and Toyota showed a modest reduction or even increased R&D investment, e.g. Hyundai.

Companies boosting R&D investment in 2009 included not only those with good sales and profits such as Huawei Technologies (27.8%) and Apple (25.4%), but also some firms, such as Bayer (8.8%) and General Electric (10.1%), that increased R&D while profits and sales fell.

The alternative energy sector continued to grow rapidly. The Scoreboard now includes 15 companies (9 more than last year) fully focused on clean energy technology. These companies, 13 based in the EU and 2 elsewhere, invested more than €500 million in R&D in 2009, an increase of 28.7%. Alternative energy investments are also made by companies classified under other sectors, e.g. oil & gas.

Differences across EU - Spain's top R&D investors resist the crisis
Within the EU, R&D growth rates differ between Member States due to their varied sector composition. Some of the biggest R&D decreases in 2009 were by companies based in countries such as Germany (down 3.2%) and France (4.5%) with a large automotive industry.

Countries like Finland (down 6%) and Sweden (6.6%) where IT hardware is a major industry for home-based companies were also hit hard.

However, Spain's top R&D investors increased investment by 15.4%, despite a drop in sales of 6.4%. This was due to large increases by top Spanish companies such as Telefónica (16%) and Acciona (29%) and the inclusion of top players such as Banco Santander (18%).

The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (DG Research and Joint Research Centre) and provides information on the world's top 1400 companies (400 from the EU and 1000 from outside) ranked by their investments in R&D. It measures the total value of their global R&D investment, irrespective of the location where the relevant R&D takes place. It does not therefore indicate trends in private sector R&D intensity – business R&D expenditure in a particular country or region as a proportion of GDP, whether that expenditure is by home-grown companies or through inward investment.

Download
2010 "EU Industrial R&D Investment Scoreboard" and other IRMA (Industrial Research Investment Monitoring and Analysis) reports: http://iri.jrc.ec.europa.eu/reports.htm

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...